Skip to main content
. Author manuscript; available in PMC: 2022 Feb 15.
Published in final edited form as: Clin Cancer Res. 2020 Oct 12;27(4):992–1002. doi: 10.1158/1078-0432.CCR-20-1690

Figure 2. Progression-free survival.

Figure 2.

Data are shown for A) all patients; and B) baseline CNS metastasis categories. The curves and medians (90% CI) were estimated using the Kaplan-Meier method. --, not available; CI, confidence interval; CNS, central nervous system; N, number of patients in population; n, number of patients in specified category; PFS, progression-free survival.